http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08325284-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91ce16ac3dbceb38cb5e6983c8c15a5a |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-645 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07G99-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 |
| filingDate | 1995-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2230c71ce17d3090d0144a9751da953 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f1bfce8694401ea4688ef817fe01ba4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db0db60a92587bc9a52af400ed57a37d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0568ef3f47c6a3ca538b8fb7e68b3849 |
| publicationDate | 1996-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H08325284-A |
| titleOfInvention | Clovalicin, a novel IL-6 activity-attenuating substance, and method for producing the same |
| abstract | (57) [Summary] [Objective] To obtain a novel IL-6 activity-reducing substance, clovarisin, which has a cancer cachexia-improving action associated with malignant transformation of lung cancer, liver cancer, colon cancer, prostate cancer, etc. Is. [Structure] Sporothrix A microorganism belonging to the genus, which has the ability to produce the IL-activity-attenuating substance clovaricin, is cultivated in a medium, and I is added to the culture. It is produced by accumulating the L-6 activity-reducing substance clovalin and collecting the IL-6 activity-reducing substance clovarisin from the culture. [Effect] This substance is expected to be useful for diseases in which IL-6 is deeply involved, such as improvement of cancer cachexia or diseases such as multiple myeloma and rheumatoid arthritis. |
| priorityDate | 1995-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 114.